Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-β

Experimental Cell Research

Volumn 258, Issue 2, 2000, Pages 374-383

  Mori, Yasuji ^a   Chen, Shu Jen ^a   Varga, John ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Skin fibroblasts; Smad signaling; Smad3; Smad7; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST;

EID: 0034255634     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4930     Document Type: Article

References (54)

1. Kingsley D. M. The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:1994;133-146.
2. Roberts A. B., McCune B. K., Sporn M. B. TGF-beta: Regulation of extracellular matrix. Kidney Int. 41:1992;557-559.
3. Inagaki Y., Truter S., Ramirez F. Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J. Biol. Chem. 269:1994;14828-14834.
4. Chang E., Goldberg H. Requirements for transforming growth factor-β regulation of the pro-α2(I) collagen and plasminogen activator inhibitor-1 promoters. J. Biol. Chem. 270:1995;4473-4477.
5. Chung K. Y., Agarwal A., Uitto J., Mauviel A. An AP-1 binding sequence is essential for regulation of the human α2(I) collagen (COL1A2) promoter activity by transforming growth factor-β J. Biol. Chem. 27:1996;3272-3278.
6. Chen S. J., Yuan W., Lo S., Trojanowska M., Varga J. Interaction of Smad3 with a proximal Smad-binding element of the human α2(I) procollagen gene promoter required for transcriptional activation by TGF-β J. Cell. Physiol. 183:2000;381-392.
7. Border W. A., Noble N. A. Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 331:1994;1286-1292.
8. Eickelberg O., Kohler E., Reichenberger F., Bertschin S., Woodtli T., Erne P., Perruchoud A. P., Roth M. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am. J. Physiol. 276:1999;L814-824.
9. Lee M., Hwang C., Lee J., Slavkin H., Warburton D. TGF-beta isoforms differentially attenuate EGF mitogenicity and receptor activity in fetal lung mesenchymal cells. Am. J. Physiol. 273:1997;L374-378.
10. Murata H., Zhou L., Ochoa S., Hasan A., Badiavas E., Falanga V. TGF-beta3 stimulates and regulates collagen synthesis through TGF-beta1-dependent and independent mechanisms. J. Invest. Dermatol. 108:1997;258-262.
11. Wrana J., Attisano L., Wieser R., Ventura F., Massague J. Mechanism of activation of the TGF-β receptor. Nature. 370:1994;341-347.
12. Kleeff J., Maruyama H., Friess H., Buchler M. W., Falb D., Korc M. Smad6 suppresses TGF-β induced growth inhibition in COLO-357 pancreatic cancer cells and in overexpressed in pancreatic cancer. Biochem. Biophys. Res. Commun. 255:1999;268-273.
13. Heldin C.-H., Miyazono K., ten Dijke P. TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature. 390:1997;465-472.
14. Derynck R., Zhang Y., Feng X.-H. Smads: Transcriptional activators of TGF-β responses. Cell. 95:1998;737-740.
15. Nigg E. A. Nucleocytoplasmic transport: Signals, mechanisms and regulation. Nature. 386:1997;779-787.
16. Lo R. S., Massague J. Ubiquitin-dependent degradation of TGF-β-activated Smad2. Nat. Cell Biol. 1:1999;472-478.
17. Topper J. N., Cai J., Qiu Y., Anderson K. R., Xu Y.-Y., Deeds J. D., Feeley R., Gimeno C. J., Woolf E. A., Tayber O., Mays G. G., Sampson B. A., Schoen F. J., Gimbrone M. A. Jr., Falb D. Vascular MADs: Two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc. Natl. Acad. Sci. USA. 94:1997;9314-9319.
18. Imamura T., Takase M., Nishihara A., Oeda E., Hanai J.-I., Kawabata M., Miyazano K. Smad6 inhibits signaling by the TGF-β superfamily. Nature. 389:1997;622-625.
19. Hayashi H., Abdollah S., Qiu Y., Cai J., Xu Y.-Y., Grinnell B. W., Richardson M. A., Topper J. N., Gimbrone M. A. Jr., Wrana J. L., Falb D. The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell. 89:1997;1165-1173.
20. Nakao A., Imamura T., Souchelnytskyi S., Kawabata M., Ishisaki A., Oeda E., Tamaki K., Hanai J.-I., Heldin C.-H., Miyazono K., ten Dijke P. TGF-β receptor-mediated signaling through Smad2, Smad3, and Smad4. EMBO J. 16:1997;5353-5362.
21. Nakao A., Afrakhte M., Morén A., Nakayama T., Christian J. L., Heuchel R., Itoh S., Kawabata M., Heldin N.-E., Heldin C.-H., ten Dijke P. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signaling. Nature. 389:1997;631-634.
22. Itoh S., Landstrom M., Hermansson A., Itoh F., Heldin C.-H., Heldin N.-E., ten Dijke P. Transforming growth factor β1 induces nuclear export of inhibitory Smad7. J. Biol. Chem. 273:1998;29195-29201.
23. Zhu H.-J., Iaria J., Sizeland A. M. Smad7 differentially regulates transforming growth factor β-mediated signaling pathways. J. Biol. Chem. 274:1999;32258-32264.
24. Chen S. J., Yuan W., Mori Y., Levenson A., Trojanowska M., Varga J. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β J. Invest. Dermatol. 112:1999;49-57.
25. Varga J., Rosenbloom J., Jimenez S. A. Transforming growth factor β (TGFβ) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J. 247:1987;597-604.
26. de Winter J. P., Roelen B. A., ten Dijke P., van der Burg B., van den Eijnden-van Raaij A. J. DPC4 (SMAD4) mediates transforming growth factor-beta1 (TGF-beta1) induced growth inhibition and transcriptional response in breast tumour cells. Oncogene. 14:1997;1891-1899.
27. Tso J. Y., Sun X. H., Kao T. H., Reece K. S., Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:1985;2485-2502.
28. Zhang Y., Feng X.-H., Wu R.-Y., Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature. 383:1996;168-171.
29. Afrakhte M., Moren A., Jossan A., Itoh S., Sampath K., Westermark B., Helden C.-H., Helden N.-E., ten Dijke P. Induction of inhibitory Smad6 and Smad7 mRNA by TGFβ family members. Biochem. Biophys. Res. Commun. 249:1998;505-511.
30. Ginsburg D., Zehab R., Yang A. Y., Rafferty U. M., Andersen P. A., Nielsen L., Dano K., Lebo R. V., Gelehrter T. D. cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J. Clin. Invest. 78:1986;1673-1680.
31. Kornblihtt A. R., Vibe-Petersen K., Baralle F. E. Isolation and characterization of cDNA clones for human and bovine fibronectin. Proc. Natl. Acad. Sci. USA. 80:1983;3128-3222.
32. Shah M., Foreman D. M., Ferguson M. W. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J. Cell Sci. 108:1995;985-1002.
33. Usui T., Takase M., Kaji Y., Suzuki K., Ishida K., Tsuru T., Miyata K., Kawabata M., Yamashita H. Extracellular matrix production regulation by TGF-β in corneal endothelial cells. Invest. Ophthalmol. Visual Sci. 39:1998;1981-1989.
34. Ulloa L., Doody J., Massague J. Inhibition of transforming growth factor-beta/SMAD signaling by the interferon-gamma/STAT pathway. Nature. 397:1999;710-713.
35. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., Gauthier J.-M. Direct binding of Smad3 and Smad4 to critical TGF-β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:1998;3091-3100.
36. Song C. Z., Tian X., Gelehrter T. D. Glucocorticoid receptor inhibits transforming growth factor-β signaling by directly targeting the transcriptional activation function of Smad3. Proc. Natl. Acad. Sci. USA. 96:1999;11776-11781.
37. Vindevoghel L., Lechleider R. J., Kon A., de Caestecker M. P., Uitto J., Roberts A. B., Mauviel A. SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. Proc. Natl. Acad. Sci. USA. 95:1998;14769-14774.
38. Poncelet A. C., De Caestecker M. P., Schnaper H. W. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Kidney Int. 56:1999;1354-1365.
39. Yanagasawa K., Osada H., Masuda A., Kondo M., Saito T., Yatabe Y., Takagi K., Takahashi T., Takahashi T. Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-β in human normal lung epithelial cells. Oncogene. 17:1998;1743-1747.
40. Edwards D. R., Murphy G., Reynolds J. J., Whitheam S. E., Docherty A. J. P., Angel P., Heath J. K. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6:1987;1899-1904.
41. Rydziel S., Varghese S., Canalis E. Transforming growth factor β1 inhibits collagenase 3 expression by transcriptional and post-transcriptional mechanisms in osteoblast cultures. J. Cell. Physiol. 170:1997;145-152.
42. Nandan D., Reiner N. E. TGF-beta attenuates the class II transactivator and reveals accessory pathway of IFN-gamma action. J. Immunol. 158:1997;1095-10101.
43. Yoshizumi M., Wang H., Hsieh C.-M., Sibinga E. S., Perrella M. A., Lee M.-E. Down-regulation of the cyclin A promoter by transforming growth factor-β1 is associated with a reduction in phosphorylated activating transcription factor-1 and cyclic AMP-responsive element-binding protein. J. Biol. Chem. 272:1997;22259-22264.
44. Shirkant P., Lee S. J., Kalvakolanu I., Ransohoff R. M., Benveniste E. N. Stimulus-specific inhibition of intercellular adhesion molecule-1 gene expression by TGF-β1. J. Immunol. 157:1996;892-900.
45. Mandriota S. J., Menoud P.-A., Pepper M. S. Transforming growth factor β1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells. J. Biol. Chem. 271:1996;11500-11505.
46. Warner B. J., Blain S. W., Seoane J., Massague J. Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway. Mol. Cell. Biol. 19:1999;5913-5922.
47. Hocever B. A., Brown T. L., Howe P. H. TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18:1999;1345-1356.
48. Nagarajan R. P., Zhang J., Li W., Chen Y. Regulation of Smad7 promoter by direct association with Smad3 and Smad4. J. Biol. Chem. 274:1999;33412-33418.
49. Watanabe R., Yamada Y., Ihara Y., Someya Y., Kubota A., Kagimot S., Kuroe A., Iwakura T., Shen Z.-P., Inada A., Adach T., Ban N., Miyawaki K., Sunaga Y., Tsuda K., Seino Y. The MH-1 domains of Smad2 and Smad3 are involved in the regulation of ALK7 signals. Biochem. Biophys. Res. Commun. 254:1999;707-712.
50. Yuan W., Yufit T., Li L., Mori Y., Chen S. J., Varga J. Negative modulation of α1(I) procollagen gene expression in human skin fibroblasts: Transcriptional inhibition by interferon-gamma. J. Cell. Physiol. 179:1999;97-108.
51. Chen X., Weisberg E., Fridmacher V., Watanabe M., Naco G., Whitman M. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature. 389:1997;85-89.
52. Liu B., Dou C. L., Prabhu L., Lai E. FAST-2 is a mammalian winged-helix protein which mediated transforming growth factor beta signals. Mol. Cell. Biol. 19:1999;424-430.
53. Hua X., Liu X., Ansari D. O., Lodish H. F. Synergistic cooperation of TFE3 and smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev. 12:1998;3084-3095.
54. Janknecht R., Wells N. J., Hunter T. TGF-beta-stimulated cooperation of Smad proteins with the coactivators CBP/p300. Genes Dev. 12:1998;2114-2119.